A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT01602315 · TERMINATED
Trial details
- NCT number
- NCT01602315
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-12
- Primary completion
- 2016-09-16
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.